Literature DB >> 970938

Preparation of phase 1Q fever antigen suitable for vaccine use.

D S Spicer, A N DeSanctis.   

Abstract

Five lots of phase 1 Q fever antigen suitable for use as vaccine were prepared utilizing the Freon-brushite method of antigen purification. Antigen concentration levels were initially adjusted turbidimetrically and later confirmed by antibody response in guinea pigs. Data showed that all lots were essentially identical in purity and antigenicity.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 970938      PMCID： PMC170010          DOI： 10.1128/aem.32.1.85-88.1976

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  10 in total

1.  STAINING RICKETTSIAE IN YOLK-SAC CULTURES.

Authors:  D F GIMENEZ
Journal:  Stain Technol       Date:  1964-05

2.  THE INFLUENCE OF PHASE ON THE PROTECTIVE POTENCY OF Q FEVER VACCINE.

Authors:  R A ORMSBEE; E J BELL; D B LACKMAN; G TALLENT
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

3.  Phase variation of the Nine Mile and other strains of Rickettsia burneti.

Authors:  M G STOKER; P FISET
Journal:  Can J Microbiol       Date:  1956-05       Impact factor: 2.419

4.  METHOD FOR THE PRODUCTION OF A PURIFIED DRY Q FEVER VACCINE.

Authors:  S Berman; R B Gochenour; G Cole; J P Lowenthal; A S Benenson
Journal:  J Bacteriol       Date:  1961-05       Impact factor: 3.490

5.  Intradermal sensitivity testing in man with a purified vaccine for Q fever.

Authors:  D B LACKMAN; E J BELL; J F BELL; E G PICKENS
Journal:  Am J Public Health Nations Health       Date:  1962-01

6.  Immunization against scrub typhus. II. Preparation of lyophilized living vaccine.

Authors:  E B JACKSON; J E SMADEL
Journal:  Am J Hyg       Date:  1951-05

7.  Preparation of purified suspensions of Coxiella burneti by Genetron extraction followed by continuous-flow ultracentrifugation.

Authors:  D R Dubois; E C Cutchins; S Berman; J P Lowenthal; R L Timchak
Journal:  Appl Microbiol       Date:  1972-05

8.  A microagglutination technique for detection and measurement of rickettsial antibodies.

Authors:  P Fiset; R A Ormsbee; R Silberman; M Peacock; S H Spielman
Journal:  Acta Virol       Date:  1969-01       Impact factor: 1.162

9.  Preparation of highly purified concentrates of Coxiella burneti.

Authors:  D S Spicer; A N DeSanctis; J M Beiler
Journal:  Proc Soc Exp Biol Med       Date:  1970-12

10.  Purification of large quantities of coxiella burnetii rickettsia by density gradient zonal centrifugation.

Authors:  P G Canonico; M J Van Zwieten; W A Christmas
Journal:  Appl Microbiol       Date:  1972-05
  10 in total
  7 in total

1.  A heat shock operon in Coxiella burnetti produces a major antigen homologous to a protein in both mycobacteria and Escherichia coli.

Authors:  M H Vodkin; J C Williams
Journal:  J Bacteriol       Date:  1988-03       Impact factor: 3.490

2.  Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine.

Authors:  R A Kishimoto; J W Johnson; R H Kenyon; M S Ascher; E W Larson; C E Pedersen
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  Enhancement of the immunogenicity of phase I antigen of Coxiella burnetii.

Authors:  R F Wachter; G P Briggs; C E Pedersen
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

4.  Experimental model for dermal granulomatous hypersensitivity in Q fever.

Authors:  M S Ascher; M A Berman; D Parker; J L Turk
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Dermal granulomatous hypersensitivity in Q fever: comparative studies of the granulomatous potential of whole cells of Coxiella burnetii phase I and subfractions.

Authors:  M S Ascher; J C Williams; M A Berman
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

6.  Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii.

Authors:  David M Waag; Marilyn J England; Christopher R Bolt; Jim C Williams
Journal:  Clin Vaccine Immunol       Date:  2008-08-13

7.  Q fever - a review.

Authors:  T J Marrie
Journal:  Can Vet J       Date:  1990-08       Impact factor: 1.008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.